Successful life sciences deal-making requires the ability to navigate the here and now while also trying to see around corners and predict the future. Depressed and unpredictable market conditions make this even more challenging. The discussion will draw from decades of experience of the panelists across various sectors of the life sciences and biotech industry, including roles as C-suite executives, investors, legal counsel, and board members in a range of life sciences companies and investment funds. Experts will share insights, strategies, and real-world experiences in crafting successful deals in a range of market conditions, and how they think about structuring and negotiating deals that best enable acceleration when market conditions improve.